R3L (p.Arg3Leu) variant of SMPD1 (Sphingomyelin phosphodiesterase)

R3L (p.Arg3Leu) in SMPD1 (Sphingomyelin phosphodiesterase) is a missense change. Clinical records from EBI and UniProt describe it as likely benign. The available variant effect predictions contribute to a CATVariant prioritization score of 0.17 / 1. The record also includes population frequency data and structural context.

R3L (p.Arg3Leu) variant details